NO20070421L - Radiosensitiviserende middel - Google Patents

Radiosensitiviserende middel

Info

Publication number
NO20070421L
NO20070421L NO20070421A NO20070421A NO20070421L NO 20070421 L NO20070421 L NO 20070421L NO 20070421 A NO20070421 A NO 20070421A NO 20070421 A NO20070421 A NO 20070421A NO 20070421 L NO20070421 L NO 20070421L
Authority
NO
Norway
Prior art keywords
fatty acid
higher fatty
radiosensitizing agent
acyl residue
radiosensitizer
Prior art date
Application number
NO20070421A
Other languages
English (en)
Norwegian (no)
Inventor
Ippei Sakimoto
Masahiko Miura
Keiko Kataoka
Kengo Sakaguchi
Fumio Sugawara
Keisuke Ohta
Takayuki Yamazaki
Original Assignee
Toyo Suisan Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Suisan Kaisha filed Critical Toyo Suisan Kaisha
Publication of NO20070421L publication Critical patent/NO20070421L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20070421A 2004-06-24 2007-01-23 Radiosensitiviserende middel NO20070421L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004186480 2004-06-24
JP2004374445 2004-12-24
PCT/JP2005/011630 WO2006001374A1 (ja) 2004-06-24 2005-06-24 放射線治療増感剤

Publications (1)

Publication Number Publication Date
NO20070421L true NO20070421L (no) 2007-01-23

Family

ID=35781821

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070421A NO20070421L (no) 2004-06-24 2007-01-23 Radiosensitiviserende middel

Country Status (13)

Country Link
US (2) US20070219145A1 (de)
EP (1) EP1734046B1 (de)
JP (1) JP3927993B2 (de)
KR (1) KR100832167B1 (de)
CN (1) CN1972955B (de)
AT (1) ATE479695T1 (de)
AU (1) AU2005257359B2 (de)
BR (1) BRPI0511824A (de)
CA (1) CA2567306C (de)
DE (1) DE602005023288D1 (de)
EA (1) EA010292B1 (de)
NO (1) NO20070421L (de)
WO (1) WO2006001374A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4435861B2 (ja) * 2007-07-20 2010-03-24 東洋水産株式会社 新規なスルホン酸化糖誘導体およびその医薬としての使用
US20100202971A1 (en) * 2009-01-16 2010-08-12 Keisuke Ohta Compound having tumor-resident property
JP6621158B1 (ja) * 2019-03-05 2019-12-18 株式会社エム・ティー・スリー 放射線増感剤
JP6903273B1 (ja) 2020-09-25 2021-07-14 株式会社エム・ティー・スリー 化合物又はその塩、及び放射性増感剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735516A (en) 1980-08-11 1982-02-26 Yamasa Shoyu Co Ltd Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JPS5767518A (en) 1980-09-17 1982-04-24 Yamasa Shoyu Co Ltd Radiosensitizing agent or agent for increasing effect of radiomimetic substance
NL8401337A (nl) * 1984-04-26 1985-11-18 Hoogovens Groep Bv Werkwijze voor het vervaardigen van cao-bevattende vuurvaste stenen.
DE3417230A1 (de) * 1984-05-10 1985-11-14 Metallgesellschaft Ag, 6000 Frankfurt Verfahren und vorrichtung zum entgasen von schwefelwasserstoffhaltigem fluessigem schwefel
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
JP2626727B2 (ja) * 1990-01-26 1997-07-02 ポーラ化成工業株式会社 ２―ニトロイミダゾール誘導体、その製造法及びこれを有効成分とする放射線増感剤
FR2733753B1 (fr) 1995-05-02 2002-06-21 Cis Bio Int Derives iodes de monosaccharides utilisables comme produits radiopharmaceutiques
WO2000006244A2 (en) * 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
JP3851461B2 (ja) * 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
JP2000212087A (ja) 1999-01-20 2000-08-02 Fujimoto Brothers:Kk ニトロ―５―デアザフラビン誘導体を有効成分とする放射線増感剤。
DE60003794T2 (de) * 1999-02-26 2004-06-17 Toyo Suisan Kaisha, Ltd. Sulforhamnosylacylglycerin-derivate und ihre verwendung als medikamente
US6518410B2 (en) * 1999-02-26 2003-02-11 Toyo Suisan Kaisha, Ltd. Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
BR0008516A (pt) 1999-02-26 2001-11-06 Toyo Suisan Kaisha Medicamento contendo um derivado sulfo piranosil acil glicerol
ATE244722T1 (de) * 1999-02-26 2003-07-15 Toyo Suisan Kaisha Sulfofukosylacylglycerin-derivate und ihre anwendung als medikamente
KR20030071029A (ko) * 2002-02-27 2003-09-03 주식회사 팜제니아 항암제 및 방사선 치료 증진제로서 유용한 조성물

Also Published As

Publication number Publication date
BRPI0511824A (pt) 2007-12-26
EA010292B1 (ru) 2008-08-29
KR20070020270A (ko) 2007-02-20
US20090253644A1 (en) 2009-10-08
US20070219145A1 (en) 2007-09-20
CN1972955A (zh) 2007-05-30
AU2005257359A1 (en) 2006-01-05
AU2005257359B2 (en) 2009-01-22
JPWO2006001374A1 (ja) 2008-04-17
EP1734046A4 (de) 2009-01-07
EP1734046B1 (de) 2010-09-01
CA2567306C (en) 2011-06-07
DE602005023288D1 (de) 2010-10-14
ATE479695T1 (de) 2010-09-15
CN1972955B (zh) 2010-08-25
CA2567306A1 (en) 2006-01-05
WO2006001374A1 (ja) 2006-01-05
EP1734046A1 (de) 2006-12-20
EA200602065A1 (ru) 2007-04-27
KR100832167B1 (ko) 2008-05-23
JP3927993B2 (ja) 2007-06-13

Similar Documents

Publication Publication Date Title
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
WO2006113552A8 (en) Cyanoarylamines
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
EP1704856A4 (de) Proteininhibitor der hsp90-familie
HK1076816A1 (de)
EP1197210A4 (de) Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
DE60032470D1 (de) Heilmittel die sulfopyranosylacylglycerolderivate enthalten
NO20070421L (no) Radiosensitiviserende middel
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
NO20043211L (no) Imidazo [1,2-a]pyridinderivat
MXPA04007048A (es) Derivados de amidoacetonitrilo.
NO20014382D0 (no) Nye immunoundertrykkende middel
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
EP1570837A4 (de) Dendrit-verlängerungs-inhibitor zur melanozyt- und haut-präparation zur äusseren verwendung, umfassend denselben.
AR041728A1 (es) Composicion fungicida para controlar enfermedades del arroz con cascara
EP1500656A4 (de) Biguanidderivat und therapeutisches diabetesmittel, das dieses enthält
EP1757593A4 (de) Therapeutisches mittel gegen nichtvirale hepatitis
DE60211686D1 (de) Pkb-3564-substanz mit die gefässneubildung hemmender wirkung
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
RU2002114173A (ru) Средство, обладающее биологической активностью
EP1464636A4 (de) Neue substanz mit antitumorwirkung/entzündungshemmender wirkung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application